# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Stephen Baxter maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target from...
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...
Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target fr...
TD Cowen analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $16 to $15.
Evercore ISI Group maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price target from $15 to $14.
RBC Capital analyst Sean Dodge maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target from $25 t...
Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $21 to $16.
Barclays analyst Steve Valiquette maintains Teladoc Health (NYSE:TDOC) with a Overweight and lowers the price target from $2...